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Introduction
Hypokalemia and many types of electrocardiographic (ECG)
abnormality are observed during the acute phase of sub-
arachnoid hemorrhage (SAH) [1–3]. Among ECG abnormali-
ties, a prolongation of the QT interval, especially when asso-
ciated with hypokalemia, deserves particular attention
R7
ECG = electrocardiogram/electrocardiography; Na+/K+-ATPase = sodium/potassium ATPase; QTc = corrected QT; SAH = subarachnoid hemor-
rhage.
Abstract
Background Subarachnoid hemorrhage (SAH) often causes a prolongation in the corrected QT (QTc)
interval during the acute phase. The aim of the present study was to examine independent risk factors
for QTc prolongation in patients with SAH by means of multivariate analysis.
Method We studied 100 patients who were admitted within 24 hours after onset of SAH. Standard
12-lead electrocardiography (ECG) was performed immediately after admission. QT intervals were
measured from the ECG and were corrected for heart rate using the Bazett formula. We measured
serum levels of sodium, potassium, calcium, adrenaline (epinephrine), noradrenaline (norepinephrine),
dopamine, antidiuretic hormone, and glucose.
Results The average QTc interval was 466±46ms. Patients were categorized into two groups based
on the QTc interval, with a cutoff line of 470ms. Univariate analyses showed significant relations
between categories of QTc interval, and sex and serum concentrations of potassium, calcium, or
glucose. Multivariate analyses showed that female sex and hypokalemia were independent risk factors
for severe QTc prolongation. Hypokalemia (<3.5mmol/l) was associated with a relative risk of 4.53 for
severe QTc prolongation as compared with normokalemia, while the relative risk associated with
female sex was 4.45 as compared with male sex. There was a significant inverse correlation between
serum potassium levels and QTc intervals among female patients.
Conclusion These findings suggest that female sex and hypokalemia are independent risk factors for
severe QTc prolongation in patients with SAH.
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because it is frequently observed in those patients who
develop life-threatening ventricular arrhythmias such as tor-
sades de pointes [1,2,4]. However, the pathogeneses of
these abnormalities during the acute phase of SAH have not
yet been fully investigated.
It is commonly believed that hypokalemia identified during the
acute phase of SAH is caused by a catecholamine surge fol-
lowing SAH [2]. In healthy male volunteers, Brown and
coworkers [5] demonstrated that serum infused adrenaline
(epinephrine) caused excessive activation of the
sodium/potassium-ATPase (Na+/K+-ATPase; Na+/K+ pump)
as a result of β2-adrenergic receptor stimulation; this resulted
in trafficking of potassium ions from extracellular to intracellu-
lar spaces, leading to a decrease in serum potassium levels.
Recent work showed that there were some relationships
between serum catecholamine levels and QT intervals during
the acute phase of SAH [1,6]. However, one cannot refute
the possibility that the catecholamine surge may influence the
QT interval indirectly via hypokalemia, because hypokalemia
(as well as hypocalcemia and hypomagnesemia) can cause a
prolongation in the QT interval [4,7–9].
In a previous preliminary study [3], we suggested that women
may be more prone than men to develop both hypokalemia
and prolongation in the corrected QT (QTc) interval on the
first day of SAH. In the present prospective study, we
assessed various possible risk factors for the QTc prolonga-
tion that is observed in SAH patients in order to examine
independent risk factors by means of multivariate analysis.
Patients and method
Patients
We prospectively studied 100 patients admitted within
24 hours after onset of SAH to the National Defense Medical
College Hospital between January 1997 and April 2002. Of
these 100 patients, 36 were men and 64 were women; mean
age on admission was 59.1±11.8 years, with a range of
21–82 years. Neurologic condition on admission was evalu-
ated according to the Hunt and Kosnik classification [10],
and severity of SAH was assessed according to Fisher’s
classification [11]. The exclusion criteria included endocrino-
logic disease, heart disease, renal failure, previous SAH or
intracerebral hemorrhage, young age (<19 years), pregnancy,
pacemaker rhythm, or taking any of the following drugs: digi-
talis, quinidine, procainamide, disopyramide, and diuretics. All
patients had brain computed tomography studies compatible
with their diagnoses. Each patient underwent a cerebral
angiogram to identify a ruptured aneurysm, except for eight
patients whose SAH were so severe that there was no indica-
tion for cerebral angiography. Patients with traumatic SAH or
SAH of unknown origin, despite assessment by cerebral
angiography, were also excluded from the study. Informed
consent was obtained from the patients and/or their
guardians.
Data collection
Standard 12-lead ECG was performed immediately after
admission. Two consecutive QT intervals were manually mea-
sured for all 12 leads of the ECG with the assessor blinded
to the name and group of the patient. The QT intervals were
measured from the beginning of the QRS complex to the
visual return of the T wave to the isoelectric line, and were
corrected for heart rate using the Bazett formula:
QTc=QT/(square root of RR interval). The mean QTc interval
was calculated from all QTc intervals measured. The intra-
observer coefficient of variation was 1.5% and the inter-
observer coefficient of variation was 1.8%. Blood samples
were obtained from the patients at the same time as ECG,
and serum levels of sodium, potassium, calcium, adrenaline,
noradrenaline (norepinephrine), dopamine, antidiuretic
hormone, and glucose were measured.
Statistical analyses
In order to identify potential risk factors for severe QTc pro-
longation, univariate analysis was conducted using the χ2
test, Student’s t test, or Mann–Whitney U test. The model
was reduced using manual back and forth procedure, with
variable selection based on the statistical significance of the
estimates (P<0.1). Multiple logistic regression analysis was
then performed to identify independent risk factors for severe
QTc prolongation. Pearson’s correlation coefficient was used
to assess the correlation between serum potassium levels
and QTc intervals. Data are expressed as means±SD.
P<0.05 was considered statistically significant and all analy-
ses were performed using the StatView Version 5.0 statistical
package (SAS Institute Inc, Cary, NC, USA).
Results
The QTc intervals on admission ranged from 328 to 629ms
in this series; it was less than 400ms in eight patients,
400–450ms in 28 patients, 450–500ms in 48 patients, and
more than 500ms in 16 patients. The average QTc interval
was 466±46ms. For the purposes of univariate analyses, the
patients were stratified into two groups based on the QTc
interval, with a cutoff line of 470ms (Table 1).
Univariate analysis
Univariate analyses demonstrated that there were significant
relationships between the category of QTc interval and
patient sex (Table 1). Significant relationships were also iden-
tified between category of QTc interval and the serum con-
centrations of potassium, calcium, or glucose (Table 1).
Severe QTc prolongation (470ms or more; n=40) was more
frequent among female SAH patients (53.1%; P=0.0004)
than among male patients (16.7%). The patients with severe
QTc prolongation had lower serum potassium levels
(3.21±0.43mmol/l; P<0.0001) than did patients with a QTc
interval of less than 470ms (3.63±0.42mmol/l).
Hypokalemia was defined as serum potassium level below
3.5mmol/l. Severe QTc prolongation was more frequently
found among SAH patients with hypokalemia (58.8%;R9
P<0.0001) than among SAH patients with normokalemia
(20.4%). Patients with severe QTc prolongation also had
lower serum calcium levels (8.29±0.52 mmol/l; P<0.1) as
compared with patients with a QTc interval of less than
470ms (8.52±0.39mmol/l). The concentration of serum
glucose was significantly higher in patients with a severely
prolonged QTc interval (207±56mg/dl; P<0.02) as com-
pared with patients with a QTc interval of less than 470ms
(178±49mg/dl). There was, however, no relation between
category of QTc interval and patient age, Hunt and Kosnik
grade, Fisher’s classification for computed tomography, site
of ruptured aneurysm, or the serum concentration of sodium,
adrenaline, noradrenaline, dopamine, or antidiuretic hormone.
There were significant inverse correlations between serum
potassium level and serum concentrations of adrenaline,
noradrenaline, dopamine, and antidiuretic hormone
(r=–0.712, –0.573, –0.432, and –0.442, respectively). Fur-
thermore, female SAH patients had lower potassium levels
(3.36±0.50mmol/l; P=0.001) than did male SAH patients
(3.65±0.36mmol/l).
Multivariate analysis
The multivariate analyses showed that female sex and
hypokalemia were independent risk factors for severe QTc
prolongation in patients with SAH. In the first analysis, the
serum potassium level was considered a continuous variable
(analysis 1, Table 2). An increase of 1mmol/l in serum potas-
sium was associated with a relative risk of 0.13 (95% confi-
dence interval 0.04–0.43; P<0.001) for severe QTc
prolongation, while female sex was associated with a relative
risk of 3.69 (95% confidence interval 1.27–10.73; P<0.02)
as compared with male sex. A second analysis (analysis 2,
Table 2) revealed that hypokalemia was associated with a rel-
ative risk of 4.53 (95% confidence interval 1.79–11.50;
P<0.002) as compared with normokalemia, while the relative
risk with female sex was 4.45 (95% confidence interval
1.55–12.78; P<0.01) as compared with male sex.
Correlation between serum potassium level and
corrected QT interval
There was a significant inverse correlation between serum
potassium level and QTc interval (Pearson’s correlation coeffi-
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Table 1
Univariate analysis of various factors for predicting severe
corrected QT prolongation in 100 SAH-patients
QTc interval (ms)
Patient variable <470 (n=60) ≥470 (n=40) P
Age (years) 59.4±12.1 58.7±11.6 NS
Sex (male : female) 30:30 6:34 0.0004
H & K grade
Grade 1 4 2 NS
Grade 2 25 9
Grade 3 12 12
Grade 4 11 10
Grade 5 8 7
Fisher’s classification
Group 2 5 2 NS
Group 3 41 27
Group 4 14 11
Aneurysm site
AcomA 16 5 NS
ICA 14 15
MCA 13 10
Upper BA 4 1
Others 8 6
Unknown 5 3
Sodium (mmol/l) 139.7±2.9 140.0±3.0 NS
Potassium (mmol/l) 3.63±0.42 3.21±0.43 < 0.0001




Calcium (mmol/l) 8.52±0.39 8.29±0.52 <0.1
Glucose (mg/dl) 178±49 207±56 < 0.02
Adrenaline (pg/ml) 783±923 747±937 NS
Noradrenaline (pg/ml) 1122±718 1173±548 NS
Dopamine (pg/ml) 37.4±35.7 34.2±18.0 NS
ADH (pg/ml) 73.9±58.7 77.4±29.4 NS
Where applicable, values are expressed as mean±SD. ADH,
antidiuretic hormone; BA, basilar artery; H & K, Hunt and Kosnik; ICA,
internal carotid artery; MCA, middle cerebral artery; QTc, corrected
QT; SAH, subarachnoid hemorrhage.
Table 2
Multivariate analysis of various factors for predicting severe
corrected QT prolongation in 100 subarachnoid hemorrhage
patients
Analyses Relative risk (95% CI) P
Analysis 1
Female sex 3.69 (1.27–10.73) <0.02
Serum potassium 0.13 (0.04–0.43) <0.001
(for each 1mmol/l)
Analysis 2
Female sex 4.45 (1.55–12.78) <0.01
Hypokalemia 4.53 (1.79–11.50) <0.002
(serum potassium <3.5mmol/l)
Potential prognostic factors were selected from Table 1. 
CI, confidence interval.R10
cient r=–0.439, P<0.0001; Fig.1a) among all SAH patients.
Furthermore, we evaluated the impact of sex on the correlation
between serum potassium levels and QTc interval. Among
female SAH patients, there was a significant inverse correlation
between serum potassium levels and QTc interval (r=–0.474,
P<0.0001; Fig.1c). On the other hand, there was no signifi-
cant correlation between the serum potassium levels and QTc
intervals (r=–0.009; Fig.1b) among male SAH patients.
Discussion
The present findings suggest that female sex and
hypokalemia are independent risk factors for severe QTc pro-
longation in patients with SAH. Recent clinical observations
and experimental data indicate sex-specific differences in
various ECG abnormalities. Several in vitro and in vivo experi-
mental studies [12–14] have shown that female sex is a
strong risk factor for drug-induced long QT interval and
cardiac arrhythmias. In a study of healthy young individuals,
Stramba-Badiale and coworkers [15] demonstrated that
females had a longer QTc interval than did males. Further-
more, recent evidence suggested that women are more
prone than men to develop torsades de pointes during admin-
istration of cardiovascular drugs that prolong cardiac repolar-
ization [9,16].
However, little is known about the mechanism responsible for
these sex related differences in the QTc interval or in the
occurrence of torsades de pointes. Several studies have indi-
cated that sex hormones play an important role in these sex
differences. Drici and coworkers [17] showed that ovariec-
tomy resulted in a shorter QT interval, and high doses of sex
hormones lengthened the QT interval. In addition, Haseroth
and coworkers [18] demonstrated that estrogen replacement
therapy significantly prolonged QTc intervals in post-
menopausal women. However, several other studies reported
that sex hormones did not affect the QT interval in healthy
women [19,20]. Various factors may be involved in the sex-
specific difference in ventricular repolarization (e.g. sex-
related differences in cardiac ionic channels). Female rabbit
ventricular myocytes had a significantly slower rapid compo-
nent of the delayed rectifier than did male cells, which might
contribute to the gender difference in the QT interval [12]. In
fact, most drugs that prolong the QTc interval have been
shown to block cardiac potassium channels, especially the
rapid component of the delayed rectifier [21,22].
Women are more susceptible to hypokalemia, especially that
due to diuretics [23,24] or SAH [3]. Considering that
hypokalemia causes a prolongation in the QTc interval
[4,7–9,25], the sex-specific difference in ventricular repolar-
ization described above might result from the sex-related dif-
ference in serum potassium levels. It is interesting that serum
potassium levels did not affect QTc interval among male SAH
patients, whereas there was a significant inverse correlation
between serum potassium levels and QTc interval among
female patients in the present study.
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Figure 1
Correlation between serum potassium levels and corrected QT (QTc)
intervals in 100 patients with subarachnoid hemorrhage (SAH). (a)
There was a significant inverse correlation between serum potassium
levels and QTc intervals (Pearson’s correlation coefficient r=–0.439,
P<0.0001) among all SAH patients. Furthermore, we evaluated the
impact of sex on the correlation between serum potassium levels and
QTc interval. (c) Among female SAH patients there was a significant
inverse correlation between serum potassium levels and QTc intervals
(r=–0.474; P<0.0001). (b) On the other hand, there was no
significant correlation between serum potassium levels and QTc
intervals among male SAH patients.R11
One mechanism that may account for this sex-specific differ-
ence in serum potassium levels is a sex-specific difference in
the activity of the Na+/K+-ATPase (Na+/K+ pump), as
reported by Lasker and coworkers [26]. Those investigators
found that Na+/K+—ATPase activity in red blood cells was
higher in females than in males, thus leading to a sex-specific
difference in the Na+/K+ balance in both the intracellular and
extracellular spaces. Another possible explanation is a differ-
ence in the total exchangeable body potassium. Kleinfeld and
coworkers [27] demonstrated that elderly women were more
vulnerable to hypokalemia, and indicated that this was possi-
bly due to age- and sex-associated differences in body mass
composition, which might result in a physiologically low total
exchangeable body potassium.
An inverse correlation between the serum catecholamines
and potassium levels suggests that a catecholamine surge
following SAH plays an important role in the pathogenesis of
hypokalemia during the acute phase of SAH. Recent evi-
dence suggested that adrenaline-induced hypokalemia
resulted from stimulation of a β-adrenoceptor linked to mem-
brane Na+/K+-ATPase, causing potassium influx [5,28]. On
the other hand, there was no correlation between serum cate-
cholamine level and QTc interval in the present series. These
findings indicate that a catecholamine surge following SAH
does not play a direct role in the pathogenesis of the QTc
prolongation in patients with SAH. Interestingly, Reid and
coworkers [28] showed that serum infused-adrenaline
caused not only hypokalemia but also a prolongation in the
QTc interval in normal volunteers, which appears to be highly
consistent with the present findings in patients with SAH.
The therapeutic implications of the present findings are clear.
When a patient with SAH is hospitalized during the acute
phase of SAH, as a rule potassium-free intravenous fluids
should not be used as initial fluid therapy, particularly in
female patients. Furthermore, careful ECG monitoring is
needed to detect critical cardiac arrhythmias as soon as pos-
sible, and avoidance of drugs that prolong ventricular repolar-
ization (quinidine, procainamide, and disopyramide) in
patients with SAH, especially female patients, is mandatory.
The findings reported here also suggest an important new
direction for further research, focusing on the detection of
critical cardiac arrhythmias in order to prevent sudden death
at an early stage in SAH.
There are some limits to the conclusions that can be drawn
from the present study. The study lacks data on ECG changes
after admission in the SAH patients, which can only be
assessed by means of continuous Holter monitoring. It was
therefore impossible to consider the influence of QTc prolon-
gation on the occurrence of critical cardiac arrhythmias such
as torsades de pointes. Further studies are required to investi-
gate the pathophysiologic basis for the QTc prolongation and
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